NASDAQ: TENX
Tenax Therapeutics Inc Stock Ownership - Who owns Tenax Therapeutics?

Insider buying vs selling

Have Tenax Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher Thomas GiordanoCEO2025-11-20538$7.59
$4.08kBuy
Christopher Thomas GiordanoCEO2025-11-19455$7.51
$3.42kBuy
Christopher Thomas GiordanoCEO2025-11-181,612$7.76
$12.50kBuy
June Sherie AlmenoffDirector2025-11-181,900$7.52
$14.28kBuy
June Sherie AlmenoffDirector2025-11-181,900$7.52
$14.28kBuy
June Sherie AlmenoffDirector2025-11-181,900$7.52
$14.28kBuy
Thomas McGauleyInterim CFO2025-11-175,000$7.23
$36.14kBuy
June Sherie AlmenoffDirector2025-11-1793$7.15
$664.95Buy
June Sherie AlmenoffDirector2025-11-1793$7.15
$664.95Buy
Thomas McGauleyInterim CFO2025-11-172,000$7.34
$14.67kBuy

1 of 2

TENX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TENX insiders and whales buy or sell their stock.

TENX Shareholders

What type of owners hold Tenax Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC96.55%6,027,985$55.40MInsider
John P. Kelley20.55%1,282,932$11.79MInsider
Ikarian Capital LLC15.50%967,600$8.89MInstitution
Vr Adviser LLC7.01%437,708$4.02MInstitution
Rtw Investments LP6.06%378,346$3.48MInstitution
Siren LLC5.64%352,441$3.24MInstitution
Boothbay Fund Management LLC5.64%352,206$3.24MInstitution
Dellora Investments LP5.62%351,071$3.23MInsider
Bvf Inc5.44%339,549$3.12MInstitution
Millennium Management LLC5.02%313,712$2.88MInstitution

1 of 3

TENX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TENX37.12%62.88%Net BuyingNet Buying
SNTI18.58%81.42%Net Buying
CELU2.33%97.67%Net Buying
NTRB3.10%49.53%
ABVC3.23%86.53%

Tenax Therapeutics Stock Ownership FAQ

Who owns Tenax Therapeutics?

Tenax Therapeutics (NASDAQ: TENX) is owned by 75.61% institutional shareholders, 128.10% Tenax Therapeutics insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Tenax Therapeutics shareholder, owning 6.03M shares representing 96.55% of the company. Armistice Capital LLC's Tenax Therapeutics shares are currently valued at $56.36M.

If you're new to stock investing, here's how to buy Tenax Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.